NEWS COMMENTARY

Cardea raises $7.8 million for graphene-based biosensors

Published:
March 26, 2019
Coverage:
Accelerating Materials Innovation More...
Activities:
Investment
8710 thumb square
by Anthony Schiavo
Average importance

Biosensors are one of the main applications for graphene thin films, bur startups like Graphene Frontiers have failed to make much commercial headway. Cardea (formerly Nanomaterial Diagnostics) has a more robust supply chain than most players in this space, and this funding is a good sign of momentum. Still, clients should only monitor until Cardea validates the value proposition of its sensors with sales or partnerships.

For the original news article, click here .


Further Reading

Haydale raises another £1 million though loans and equity

News Commentary | January 3, 2019

Haydale is a leading developer of graphene products and has expanded its business through acquisitions in the U.S. and ASEAN. Not all these acquisitions are cash flow‑positive, and its silicon carbide business in particular has been a drag on finances. This new funding means Haydale should be able ... Not part of subscription

XG Sciences

Company Profile | January 24, 2019

Produces high‑quality graphene nanoplatelets (GNPs) from graphite using chemical intercalation followed by microwave exfoliation or mechanical exfoliation Focused on product development with partners, with the goal of transitioning into being a materials supplier for industrial‑scale quantities... Not part of subscription

Applied Graphene Materials launches graphene-based thermal paste adhesives and anticorrosion primers

News Commentary | October 23, 2018

Applied Graphene Materials is notable for its partnerships; now, those partnerships seem to be paying off with new products. It remains to be seen how much of a revenue driver these products will be; unlike XG Sciences' recent announcement, there is no clear buyer here. Still, clients should view it... Not part of subscription